Full-Time
Senior Research Associate/Associate Scientist
Programs
Posted on 5/21/2024
BigHat Biosciences
51-200 employees
Develops antibody therapies using machine learning
Senior, Expert
San Mateo, CA, USA
- MS or PhD in the biological sciences or engineering
- Familiarity with protein biochemistry/biophysics or protein engineering
- Strongly self-motivated individual with attention to detail
- Driven, team-oriented, and excited to work in a dynamic startup environment
- Plan and execute experiments to discover antibodies or optimize antibody expression
- Contribute to the development and optimization of new assays
- Create SOPs for new or modified assays
- Follow laboratory protocols and keep detailed records
- Communicate progress and challenges regularly
- Analyze & summarize results and critical problems
- Present results to a collaborative, cross-functional team
BigHat Biosciences focuses on developing antibody therapies using machine learning and synthetic biology. Their main product is the Milliner platform, which integrates a wet lab with advanced machine learning to streamline the discovery and engineering of antibodies. This platform enables the rapid synthesis, purification, and characterization of numerous recombinant antibodies each week, allowing for quicker development of effective treatments for challenging diseases like infections and cancers. Unlike many competitors, BigHat emphasizes a balance between high performance and a supportive work environment. The company's goal is to create safer and more effective therapies for patients while maintaining a family-friendly culture.
Company Stage
Series B
Total Funding
$99.4M
Headquarters
San Carlos, California
Founded
2019
6 month growth
↑ 12%1 year growth
↑ 28%2 year growth
↑ 92%
Simplify's Take
What believers are saying
- BigHat's recent $75 million Series B funding round, led by prominent investors, provides substantial financial backing for aggressive expansion and product development.
- The company's emphasis on work-life balance and a family-friendly culture makes it an attractive workplace in the high-pressure biotech industry.
- Collaborations with major pharmaceutical companies like Merck and Johnson & Johnson offer significant opportunities for career growth and exposure to cutting-edge research.
What critics are saying
- The competitive biotech landscape requires continuous innovation to maintain a leading position, which can be resource-intensive.
- Dependence on strategic partnerships for growth could pose risks if these collaborations do not yield expected results.
What makes BigHat Biosciences unique
- BigHat Biosciences leverages its proprietary Milliner platform, which integrates synthetic biology and machine learning, to accelerate the discovery and engineering of high-quality antibodies, setting it apart from traditional biotech approaches.
- The company's focus on difficult-to-treat diseases, such as certain infections and cancers, positions it uniquely in the biotech market, targeting areas with significant unmet medical needs.
- Strategic collaborations with industry giants like Johnson & Johnson and Merck highlight BigHat's credibility and the advanced capabilities of its Milliner platform.